These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 7657029)

  • 1. Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
    Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Kelly JM; Jackson NC; Sönksen PH
    Diabetes; 1995 Sep; 44(9):1059-65. PubMed ID: 7657029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
    Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
    Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
    Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Naoumova R; Slavin BM; Thompson GR; Sönksen PH
    Diabetologia; 1995 Aug; 38(8):959-67. PubMed ID: 7589883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study.
    Duvillard L; Pont F; Florentin E; Galland-Jos C; Gambert P; Vergès B
    Eur J Clin Invest; 2000 Aug; 30(8):685-94. PubMed ID: 10964160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of Troglitazone in patients with diet-controlled type 2 diabetes.
    Robinson AC; Jeffs JA; Gray RG; Bannister PA; Mather H; Gallagher JJ; Robinson S; Nattrass M; Venkatesan S; Halliday D; Johnston DG
    Eur J Clin Invest; 2004 Jan; 34(1):29-36. PubMed ID: 14984435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men.
    Riches FM; Watts GF; van Bockxmeer FM; Hua J; Song S; Humphries SE; Talmud PJ
    J Lipid Res; 1998 Sep; 39(9):1752-8. PubMed ID: 9741687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men.
    Riches FM; Watts GF; Hua J; Stewart GR; Naoumova RP; Barrett PH
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2854-61. PubMed ID: 10443691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.
    Malmström R; Packard CJ; Caslake M; Bedford D; Stewart P; Yki-Järvinen H; Shepherd J; Taskinen MR
    Diabetologia; 1997 Apr; 40(4):454-62. PubMed ID: 9112023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of acute inhibitory effect of insulin on chylomicron production in type 2 diabetes.
    Nogueira JP; Maraninchi M; Béliard S; Padilla N; Duvillard L; Mancini J; Nicolay A; Xiao C; Vialettes B; Lewis GF; Valéro R
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1039-44. PubMed ID: 22308041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.
    Chan DC; Watts GF; Redgrave TG; Mori TA; Barrett PH
    Metabolism; 2002 Aug; 51(8):1041-6. PubMed ID: 12145779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a six-month exercise program on very low-density lipoprotein apolipoprotein B secretion in type 2 diabetes.
    Alam S; Stolinski M; Pentecost C; Boroujerdi MA; Jones RH; Sonksen PH; Umpleby AM
    J Clin Endocrinol Metab; 2004 Feb; 89(2):688-94. PubMed ID: 14764782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose tissue compartments and the kinetics of very-low-density lipoprotein apolipoprotein B-100 in non-obese men.
    Watts GF; Chan DC; Barrett PH
    Metabolism; 2002 Sep; 51(9):1206-10. PubMed ID: 12200768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Studies before and after sulfonylurea therapy.
    Taskinen MR; Beltz WF; Harper I; Fields RM; Schonfeld G; Grundy SM; Howard BV
    Diabetes; 1986 Nov; 35(11):1268-77. PubMed ID: 3530855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
    Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
    Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals.
    Lewis GF; Uffelman KD; Szeto LW; Steiner G
    Diabetes; 1993 Jun; 42(6):833-42. PubMed ID: 8495807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.
    Taskinen MR; Packard CJ; Shepherd J
    Diabetes; 1990 Sep; 39(9):1017-27. PubMed ID: 2200727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein B mRNA editing and apolipoprotein gene expression in the liver of hyperinsulinemic fatty Zucker rats: relationship to very low density lipoprotein composition.
    Elam MB; von Wronski MA; Cagen L; Thorngate F; Kumar P; Heimberg M; Wilcox HG
    Lipids; 1999 Aug; 34(8):809-16. PubMed ID: 10529091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects.
    Watts GF; Naoumova RP; Kelly JM; Riches FM; Croft KD; Thompson GR
    Am J Physiol; 1997 Sep; 273(3 Pt 1):E462-70. PubMed ID: 9316434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fat compartments and apolipoprotein B-100 kinetics in overweight-obese men.
    Watts GF; Chan DC; Barrett PH; Susekov AV; Hua J; Song S
    Obes Res; 2003 Jan; 11(1):152-9. PubMed ID: 12529498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.